CVE-2026-85104: Sooma tDCS Home Therapy · Improper enforcement of message integrity during transmission in a communication channel
Affects Sooma tDCS Home TherapySource CVE Database V5
Not known to be exploited · CVSS 5.3 Medium.
Data as of 31 Oct 2026, 20:20 UTC
- EPSS
- 0.1% chance of exploitation in 30 days – higher than 5% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 16 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 31 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| SoomaSooma tDCS Home Therapy | Affected
| Fixed in– |
AI-suggested
Until a fix is available, users should limit Bluetooth exposure and ensure the device is used in secure environments to reduce risk of unauthorized access.
Description
CVE-2026-85104 is a medium severity vulnerability in the Sooma 2GEN brain stimulator device. It involves improper enforcement of message integrity during Bluetooth communication, allowing an attacker within Bluetooth range to make unauthenticated changes to brain stimulation parameters. This could potentially affect the safety and efficacy of the device's operation.